Nothing to Disclose. . 21 USC 360ii. FDA has authority to: Plan, conduct, coordinate, and support research, development, training and operational activities to minimize the emissions of and the exposure of people to, unnecessary electronic product radiation. Goals. National dose registryNatio
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
1. FDA Perspective on Radiation Dose Monitoring ACR Dose Monitoring Forum
Donald L. Miller, M.D. FACR
Acting Chief, Diagnostic Devices Branch
Division of Mammography Quality and Radiation Programs
Center for Devices and Radiological Health
Food and Drug Administration
2. Nothing to Disclose
3. 21 USC 360ii FDA has authority to:
Plan, conduct, coordinate, and support research, development, training and operational activities to minimize the emissions of and the exposure of people to, unnecessary electronic product radiation
4. Goals National dose registry
National reference levels
5. FDA Dose Reduction Initiative The healthcare professional community, in collaboration with FDA, should continue efforts to develop DRLs for CT, fluoroscopy, and nuclear medicine procedures locally and also through a national radiation dose registry. Requirements for CT and fluoroscopic device capability to record radiation dose information for use in patient medical records or a radiation dose registry. Provide patients with tools to track their personal medical imaging history.